JP2006515587A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006515587A5 JP2006515587A5 JP2004560041A JP2004560041A JP2006515587A5 JP 2006515587 A5 JP2006515587 A5 JP 2006515587A5 JP 2004560041 A JP2004560041 A JP 2004560041A JP 2004560041 A JP2004560041 A JP 2004560041A JP 2006515587 A5 JP2006515587 A5 JP 2006515587A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- hydrogen
- composition
- pharmaceutically acceptable
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- AYXYPKUFHZROOJ-ZETCQYMHSA-N CC(C)C[C@@H](CC(O)=O)CN Chemical compound CC(C)C[C@@H](CC(O)=O)CN AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43349102P | 2002-12-13 | 2002-12-13 | |
| PCT/IB2003/005682 WO2004054563A1 (en) | 2002-12-13 | 2003-12-03 | Alpha-2-delta ligand for the treatment of sexual dysfunction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006515587A JP2006515587A (ja) | 2006-06-01 |
| JP2006515587A5 true JP2006515587A5 (https=) | 2006-10-12 |
Family
ID=32595199
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004560041A Withdrawn JP2006515587A (ja) | 2002-12-13 | 2003-12-03 | 性的不能を治療する方法 |
| JP2004560036A Pending JP2006511527A (ja) | 2002-12-13 | 2003-12-03 | 種々の薬学的用途のためのα２δリガンド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004560036A Pending JP2006511527A (ja) | 2002-12-13 | 2003-12-03 | 種々の薬学的用途のためのα２δリガンド |
Country Status (15)
| Country | Link |
|---|---|
| US (8) | US7432299B2 (https=) |
| EP (2) | EP1572172A1 (https=) |
| JP (2) | JP2006515587A (https=) |
| KR (2) | KR100703103B1 (https=) |
| CN (8) | CN1726021A (https=) |
| AU (3) | AU2003303037A1 (https=) |
| BR (2) | BR0316753A (https=) |
| CA (3) | CA2451267A1 (https=) |
| MX (2) | MXPA05005665A (https=) |
| MY (1) | MY140525A (https=) |
| NZ (2) | NZ566452A (https=) |
| PL (2) | PL377729A1 (https=) |
| TW (2) | TW200412241A (https=) |
| WO (3) | WO2004054559A1 (https=) |
| ZA (6) | ZA200503863B (https=) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL189872B1 (pl) | 1996-07-24 | 2005-10-31 | Warner Lambert Co | Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu |
| US20050043407A1 (en) * | 2003-08-22 | 2005-02-24 | Pfizer Inc | Pharmaceutical composition for the prevention and treatment of addiction in a mammal |
| US20050043345A1 (en) * | 2003-08-22 | 2005-02-24 | Pfizer Inc | Pharmaceutical composition for the prevention and treatment of addiction in a mammal |
| US20050043406A1 (en) * | 2003-08-22 | 2005-02-24 | Pfizer Inc | Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
| CA2539976A1 (en) | 2003-09-25 | 2005-04-07 | Warner-Lambert Company Llc | Therapeutic beta aminoacids |
| PE20060272A1 (es) | 2004-05-24 | 2006-05-22 | Glaxo Group Ltd | (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a |
| DK1766077T3 (da) | 2004-06-21 | 2012-07-16 | Univ Leland Stanford Junior | Differentielt udtrykte gener og veje i bipolar forstyrrelse og/eller alvorlig depressiv forstyrrelse |
| PT1791423E (pt) * | 2004-08-02 | 2013-08-02 | Sami Labs Ltd | Composições e métodos para o tratamento de condições dermatológicas hiperproliferativas |
| AU2006249866B2 (en) | 2005-05-26 | 2011-10-13 | Aldeyra Therapeutics, Inc. | Compositions and methods of treating retinal disease |
| GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
| WO2007027476A2 (en) * | 2005-08-26 | 2007-03-08 | Xenoport, Inc. | Treating premature ejaculation using gabapentin and pregabalin prodrugs |
| DE102005050377A1 (de) * | 2005-10-21 | 2007-04-26 | Bayer Healthcare Ag | Heterocyclische Verbindungen und ihre Verwendung |
| US20080161393A1 (en) * | 2006-12-08 | 2008-07-03 | Barrett Ronald W | Use of prodrugs of GABA analogs for treating disease |
| DE102007001804A1 (de) * | 2007-01-12 | 2008-07-17 | Johann Wolfgang Goethe-Universität Frankfurt am Main | Verwendung von GABAB-Rezeptor selektiven Agonisten zur Behandlung entzündlicher Hauterkrankungen |
| CA2703472A1 (en) * | 2007-10-26 | 2009-04-30 | The Scripps Research Institute | Methods for treating substance dependence |
| WO2009059316A1 (en) * | 2007-11-02 | 2009-05-07 | The Board Of Trustees Of The Leland Stanford Junior University | Fgf9-related methods for treating anxiety |
| US7868043B2 (en) | 2008-01-25 | 2011-01-11 | Xenoport, Inc. | Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use |
| EP2250148B1 (en) * | 2008-01-25 | 2016-08-17 | XenoPort, Inc. | Crystalline form of calcium-salts of (3s)-aminomethyl-5-methyl-hexanoic acids and methods of use |
| ES2601852T3 (es) * | 2008-01-25 | 2017-02-16 | Xenoport, Inc. | Forma cristalina de sales de calcio de ácidos (3S)-aminometil-5-metil-hexanoicos y métodos de uso |
| SG157299A1 (en) | 2008-05-09 | 2009-12-29 | Agency Science Tech & Res | Diagnosis and treatment of kawasaki disease |
| WO2011072141A1 (en) | 2009-12-11 | 2011-06-16 | Neuron Systems, Inc. | Compositions and methods for the treatment of macular degeneration |
| CN102432525A (zh) * | 2011-10-20 | 2012-05-02 | 苏州康润医药有限公司 | 3-苄基-3-氮杂二环[2,1,0]己烷的实用合成方法 |
| AU2013361314A1 (en) | 2012-12-20 | 2015-07-02 | Aldeyra Therapeutics, Inc. | Peri-carbinols |
| US8992951B2 (en) * | 2013-01-09 | 2015-03-31 | Sapna Life Sciences Corporation | Formulations, procedures, methods and combinations thereof for reducing or preventing the development, or the risk of development, of neuropathology as a result of trauma |
| CN117045653A (zh) | 2013-01-23 | 2023-11-14 | 奥尔德拉医疗公司 | 与毒性醛相关的疾病和治疗 |
| US10111862B2 (en) | 2013-01-25 | 2018-10-30 | Aldeyra Therapeutics, Inc. | Traps in the treatment of macular degeneration |
| EP3160445B1 (en) | 2014-06-26 | 2021-10-20 | Island Breeze Systems Ca, LLC | Mdi related products and methods of use |
| ZA201603150B (en) * | 2015-05-12 | 2017-08-30 | Cipla Europe Nv | Inhaler device |
| US10550085B2 (en) | 2015-08-21 | 2020-02-04 | Aldeyra Therapeutics, Inc. | Deuterated compounds and uses thereof |
| CA3022665A1 (en) | 2016-05-09 | 2017-11-16 | Aldeyra Therapeutics, Inc. | Combination treatment of ocular inflammatory disorders and diseases |
| CA3054811A1 (en) | 2017-03-16 | 2018-09-20 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
| BR112019024944A2 (pt) | 2017-05-26 | 2020-06-23 | Novassay Sa | Subunidade auxilária de canal de cálcio com porta de tensão alfa 2 delta e suas utilizações |
| WO2019075136A1 (en) | 2017-10-10 | 2019-04-18 | Aldeyra Therapeutics, Inc. | TREATMENT OF INFLAMMATORY DISORDERS |
| AU2019319740A1 (en) | 2018-08-06 | 2021-03-25 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
| WO2020223717A1 (en) | 2019-05-02 | 2020-11-05 | Aldeyra Therapeutics, Inc. | Process for preparation of aldehyde scavenger and intermediates |
| JP2022530967A (ja) | 2019-05-02 | 2022-07-05 | アルデイラ セラピューティクス， インコーポレイテッド | 多形化合物およびその使用 |
| US20220296548A1 (en) * | 2019-10-25 | 2022-09-22 | Kyoto University | Preventative or therapeutic agent for tauopathy |
| WO2021231792A1 (en) | 2020-05-13 | 2021-11-18 | Aldeyra Therapeutics, Inc. | Pharmaceutical formulations and uses thereof |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2503059A (en) * | 1950-04-04 | Nxchj | ||
| US2599000A (en) * | 1950-09-02 | 1952-06-03 | Smith Kline French Lab | Nu, nu-disubstituted-beta-halo-alkylamines |
| US3238215A (en) * | 1963-10-17 | 1966-03-01 | Sterling Drug Inc | 1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines |
| IT1066857B (it) * | 1965-12-15 | 1985-03-12 | Acraf | Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione |
| US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
| NL175059C (nl) * | 1974-02-23 | Boehringer Mannheim Gmbh | Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten. | |
| DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US4087544A (en) * | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
| US4026894A (en) * | 1975-10-14 | 1977-05-31 | Abbott Laboratories | Antihypertensive agents |
| US4188390A (en) * | 1977-11-05 | 1980-02-12 | Pfizer Inc. | Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines |
| FR2421888A1 (fr) * | 1978-02-06 | 1979-11-02 | Synthelabo | Amides d'alkylene-diamines et leur application en therapeutique |
| IT1094076B (it) * | 1978-04-18 | 1985-07-26 | Acraf | Cicloalchiltriazoli |
| JPS56110665A (en) * | 1980-02-08 | 1981-09-01 | Yamanouchi Pharmaceut Co Ltd | Sulfamoyl-substituted phenetylamine derivative and its preparation |
| US5084479A (en) * | 1990-01-02 | 1992-01-28 | Warner-Lambert Company | Novel methods for treating neurodegenerative diseases |
| KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| US6197819B1 (en) * | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
| GB9117716D0 (en) * | 1991-08-16 | 1991-10-02 | Lynxvale Ltd | Gaba derivatives and their therapeutic application |
| HU222776B1 (hu) | 1992-05-20 | 2003-10-28 | Northwestern University | (S)-(+)-4-amino-3-(2-metil-propil)-butánsav előállításának új hexánsav- és butándisav-származék köztitermékei és ezek előállítása |
| US5510381A (en) * | 1995-05-15 | 1996-04-23 | Warner-Lambert Company | Method of treatment of mania and bipolar disorder |
| GB9518953D0 (en) * | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| US5929088A (en) | 1996-02-07 | 1999-07-27 | Warner-Lambert Company | Cyclic amino acids as pharmaceutical agents |
| US6020370A (en) | 1996-03-14 | 2000-02-01 | Warner-Lambert Company | Bridged cyclic amino acids as pharmaceutical agents |
| UA49011C2 (uk) | 1996-03-14 | 2002-09-16 | Варнер-Ламберт Компані | Похідні циклічної амінокислоти, фармацевтична композиція та спосіб лікування |
| US6372792B1 (en) * | 1996-04-26 | 2002-04-16 | Guy Chouinard | Method for treating anxiety, anxiety disorders and insomnia |
| PL189872B1 (pl) * | 1996-07-24 | 2005-10-31 | Warner Lambert Co | Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu |
| WO1998017627A1 (en) | 1996-10-23 | 1998-04-30 | Warner-Lambert Company | Substituted gamma aminobutyric acids as pharmaceutical agents |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| HRP980342A2 (en) * | 1997-06-25 | 1999-02-28 | Warner Lambert Co | Anti-inflammatory method |
| WO1999008670A1 (en) * | 1997-08-20 | 1999-02-25 | Guglietta, Antonio | Gaba analogs to prevent and treat gastrointestinal damage |
| HUP0004310A3 (en) | 1997-10-27 | 2001-11-28 | Warner Lambert Co | Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents |
| CA2314993A1 (en) | 1997-12-16 | 1999-06-24 | Pfizer Products Inc. | Combination effective for the treatment of impotence |
| DK1045839T3 (da) | 1997-12-16 | 2004-07-05 | Warner Lambert Co | Hidtil ukendte aminer som farmaceutiske midler |
| US6518289B1 (en) | 1997-12-16 | 2003-02-11 | Pfizer, Inc. | 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| NZ503980A (en) | 1997-12-16 | 2002-09-27 | Warner Lambert Co | 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (= gabapentin analogues), pharmaceuticals thereof, and their use in the treatment of neurological disorders |
| US5945117A (en) * | 1998-01-30 | 1999-08-31 | Pentech Pharmaceuticals, Inc. | Treatment of female sexual dysfunction |
| EP1082306A1 (en) * | 1998-05-26 | 2001-03-14 | Warner-Lambert Company | Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| JP2002520277A (ja) * | 1998-07-09 | 2002-07-09 | ワーナー−ランバート・カンパニー | 不眠症を治療する方法 |
| US5945424A (en) * | 1998-07-31 | 1999-08-31 | G & H Associates, Inc. | Treatment of periodic limb movement syndrome |
| WO2000015611A1 (en) * | 1998-09-14 | 2000-03-23 | Warner-Lambert Company | Branched alkyl pyrrolidine-3-carboxylic acids |
| HUP0200738A3 (en) * | 1999-04-08 | 2003-03-28 | Warner Lambert Co | Method of the treatment of incontinence |
| AU4307800A (en) * | 1999-04-30 | 2000-11-17 | Merab Lomia | New indication for use of antiepileptic agents and medicines |
| AU3735000A (en) * | 1999-05-05 | 2000-11-21 | Warner-Lambert Company | Modulation of substance p by gaba analogs and methods relating thereto |
| RS50352B (sr) | 1999-06-10 | 2009-11-10 | Warner-Lambert Company Llc., | Monosupstituisane 3-propil gama-aminobuterne kiseline |
| HN2000000224A (es) | 1999-10-20 | 2001-04-11 | Warner Lambert Co | Aminoacidos biciclicos como agentes farmaceuticos |
| WO2001042190A1 (en) * | 1999-12-08 | 2001-06-14 | Warner-Lambert Company | Method for the stereoselective synthesis of cyclic amino acids |
| ATE355836T1 (de) * | 2000-01-31 | 2007-03-15 | Genaera Corp | Inhibitoren der mucin-synthese |
| GB0007884D0 (en) * | 2000-03-31 | 2000-05-17 | Pfizer Ltd | Diphenyl ether compounds useful in therapy |
| JP2003535061A (ja) * | 2000-05-31 | 2003-11-25 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | エンドセリン受容体拮抗剤および疼痛軽減特性を有する抗癲癇化合物または鎮痛剤の複合物 |
| PL359872A1 (en) * | 2000-06-26 | 2004-09-06 | Warner-Lambert Company | Gabapentin analogues for sleep disorders |
| GB2365425A (en) | 2000-08-01 | 2002-02-20 | Parke Davis & Co Ltd | Alkyl amino acid derivatives useful as pharmaceutical agents |
| DK1317426T3 (da) | 2000-09-14 | 2006-01-09 | Gruenenthal Gmbh | Betal-thio-aminosyrer |
| CA2356829A1 (en) * | 2000-09-22 | 2002-03-22 | Warner-Lambert Company | Method for treating asthma using pregabalin |
| PE20021046A1 (es) | 2000-09-30 | 2002-12-14 | Gruenenthal Chemie | Sulfonilguanidina que tiene afinidad al punto de fijacion de gabapentina |
| DE10048715A1 (de) | 2000-09-30 | 2004-05-19 | Grünenthal GmbH | Verwendung von Aminosäure zur Behandlung von Schmerz |
| AU2002211863A1 (en) | 2000-10-06 | 2002-04-15 | Xenoport, Inc. | Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration |
| US6620829B2 (en) * | 2000-10-17 | 2003-09-16 | Warner-Lambert Company | Method of treating noninflammatory cartilage damage |
| GB2368579A (en) | 2000-10-31 | 2002-05-08 | Parke Davis & Co Ltd | Azole pharmaceutical agents |
| WO2002042414A2 (en) | 2000-11-17 | 2002-05-30 | Xenoport, Inc. | Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| CA2430298A1 (en) * | 2000-11-30 | 2002-06-06 | Banavara Lakshman Mylari | Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| BR0208922A (pt) | 2001-04-19 | 2004-04-20 | Warner Lambert Co | Aminoácidos bicìclicos ou tricìclicos fundidos |
| DE60213592T2 (de) * | 2001-05-25 | 2007-08-09 | Warner-Lambert Co. Llc | Flüssige pharmazeutische zusammensetzung |
| CA2449729C (en) | 2001-06-11 | 2009-11-03 | Xenoport, Inc. | Prodrugs of gaba analogs, compositions and uses thereof |
| ITMI20011308A1 (it) | 2001-06-21 | 2002-12-21 | Nicox Sa | Farmaci per il dolore cronico |
| NI200300043A (es) * | 2002-03-28 | 2003-11-05 | Warner Lambert Co | AMINOACIDOS CON AFINIDAD POR LA PROTEINA a2DELTA. |
-
2003
- 2003-11-27 CA CA002451267A patent/CA2451267A1/en not_active Abandoned
- 2003-12-02 US US10/726,878 patent/US7432299B2/en not_active Expired - Fee Related
- 2003-12-03 WO PCT/IB2003/005669 patent/WO2004054559A1/en not_active Ceased
- 2003-12-03 MX MXPA05005665A patent/MXPA05005665A/es unknown
- 2003-12-03 MX MXPA05006318A patent/MXPA05006318A/es unknown
- 2003-12-03 BR BR0316753-4A patent/BR0316753A/pt not_active IP Right Cessation
- 2003-12-03 PL PL377729A patent/PL377729A1/pl not_active Application Discontinuation
- 2003-12-03 AU AU2003303037A patent/AU2003303037A1/en not_active Abandoned
- 2003-12-03 CA CA002509600A patent/CA2509600A1/en not_active Abandoned
- 2003-12-03 JP JP2004560041A patent/JP2006515587A/ja not_active Withdrawn
- 2003-12-03 CN CNA2003801060090A patent/CN1726021A/zh active Pending
- 2003-12-03 KR KR1020057010548A patent/KR100703103B1/ko not_active Expired - Fee Related
- 2003-12-03 CA CA002509611A patent/CA2509611A1/en not_active Abandoned
- 2003-12-03 WO PCT/IB2003/005682 patent/WO2004054563A1/en not_active Ceased
- 2003-12-03 BR BR0317273-2A patent/BR0317273A/pt not_active IP Right Cessation
- 2003-12-03 NZ NZ566452A patent/NZ566452A/en not_active IP Right Cessation
- 2003-12-03 EP EP03813228A patent/EP1572172A1/en not_active Ceased
- 2003-12-03 JP JP2004560036A patent/JP2006511527A/ja active Pending
- 2003-12-03 AU AU2003303038A patent/AU2003303038B2/en not_active Ceased
- 2003-12-03 AU AU2003283708A patent/AU2003283708A1/en not_active Abandoned
- 2003-12-03 WO PCT/IB2003/005640 patent/WO2004054577A1/en not_active Ceased
- 2003-12-03 CN CNA2003801060137A patent/CN1726023A/zh active Pending
- 2003-12-03 NZ NZ539971A patent/NZ539971A/en unknown
- 2003-12-03 CN CNB2003801047024A patent/CN100367946C/zh not_active Expired - Fee Related
- 2003-12-03 CN CNA2003801059680A patent/CN1726015A/zh active Pending
- 2003-12-03 KR KR1020057010589A patent/KR20050085537A/ko not_active Ceased
- 2003-12-03 PL PL377656A patent/PL377656A1/pl not_active Application Discontinuation
- 2003-12-03 CN CNA200710110291XA patent/CN101283995A/zh active Pending
- 2003-12-03 CN CNA2003801059657A patent/CN1726022A/zh active Pending
- 2003-12-03 EP EP03775689A patent/EP1572183A1/en not_active Withdrawn
- 2003-12-03 CN CNB2003801052910A patent/CN100430048C/zh not_active Expired - Fee Related
- 2003-12-03 CN CNA2008102138044A patent/CN101417129A/zh active Pending
- 2003-12-09 US US10/731,605 patent/US20040132636A1/en not_active Abandoned
- 2003-12-10 MY MYPI20034741A patent/MY140525A/en unknown
- 2003-12-12 US US10/735,398 patent/US20040143014A1/en not_active Abandoned
- 2003-12-12 TW TW092135260A patent/TW200412241A/zh unknown
- 2003-12-12 TW TW092135262A patent/TWI286934B/zh not_active IP Right Cessation
-
2005
- 2005-05-13 ZA ZA200503863A patent/ZA200503863B/en unknown
- 2005-05-13 ZA ZA200503861A patent/ZA200503861B/en unknown
- 2005-05-13 ZA ZA200503862A patent/ZA200503862B/en unknown
- 2005-05-25 ZA ZA200504271A patent/ZA200504271B/en unknown
- 2005-05-31 ZA ZA200504475A patent/ZA200504475B/en unknown
- 2005-06-09 ZA ZA200504724A patent/ZA200504724B/xx unknown
-
2007
- 2007-02-15 US US11/675,389 patent/US20070293570A1/en not_active Abandoned
- 2007-03-19 US US11/687,978 patent/US20070213401A1/en not_active Abandoned
- 2007-03-19 US US11/688,001 patent/US20070161707A1/en not_active Abandoned
- 2007-03-19 US US11/687,964 patent/US20070161706A1/en not_active Abandoned
- 2007-03-19 US US11/687,993 patent/US20070276039A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006515587A5 (https=) | ||
| JP5373405B2 (ja) | 選択的アンドロゲン受容体モジュレーター | |
| RU2306309C2 (ru) | Производное 8-азапростагландина, фармацевтическая композиция, агент для профилактики заболеваний | |
| ES2544532T3 (es) | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso | |
| JP2001521020A5 (https=) | ||
| CN105120866B (zh) | 与毒性醛相关的疾病和治疗 | |
| JP2021176846A (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| US20100004481A1 (en) | L-threonine derivatives of high therapeutic index | |
| JP2009524675A5 (https=) | ||
| CA2514384A1 (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
| RU2012121577A (ru) | Замещенные 3-фенилпропионовые кислоты и их применение | |
| JP2005531516A5 (https=) | ||
| JP2006143737A5 (https=) | ||
| JP2004501189A5 (https=) | ||
| WO2008054454A2 (en) | Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents | |
| WO1993003013A1 (fr) | Derives d'indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant | |
| JP2018524304A5 (https=) | ||
| JP2003503449A5 (https=) | ||
| JP2006504738A5 (https=) | ||
| JP2009517411A5 (https=) | ||
| CA2589744A1 (en) | Pyrrolinidium derivatives as m3 muscarinic receptors | |
| JP2005516035A5 (https=) | ||
| JPS61257967A (ja) | ２−ピロリドン誘導体 | |
| JPH1036365A5 (https=) | ||
| JP2007525533A5 (https=) |